Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 27 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 3 institutions in 2 countries.
Yun ZhangHenan Key Laboratory of Immunology and Targeted Therapy, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, School of Laboratory Medicine, Xinxiang Medical University Xinxiang 453003 PR China zhangyun0126@126.com +86 373 3029977 +86 373 3029977.ORCID https://orcid.org/0000-0002-3274-2792
Shuyou ShiHenan Key Laboratory of Immunology and Targeted Therapy, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, School of Laboratory Medicine, Xinxiang Medical University Xinxiang 453003 PR China zhangyun0126@126.com +86 373 3029977 +86 373 3029977.
Jiajia XingSchool of International Education, Xinxiang Medical University Xinxiang 453003 PR China.
Wenqing TanHenan Key Laboratory of Immunology and Targeted Therapy, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, School of Laboratory Medicine, Xinxiang Medical University Xinxiang 453003 PR China zhangyun0126@126.com +86 373 3029977 +86 373 3029977.
Chenguang ZhangHenan Key Laboratory of Immunology and Targeted Therapy, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, School of Laboratory Medicine, Xinxiang Medical University Xinxiang 453003 PR China zhangyun0126@126.com +86 373 3029977 +86 373 3029977.
Lin ZhangSchool of Innovation and Entrepreneurship, Xinxiang Medical University Xinxiang 453003 PR China.
Huan YuanHenan Key Laboratory of Immunology and Targeted Therapy, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, School of Laboratory Medicine, Xinxiang Medical University Xinxiang 453003 PR China zhangyun0126@126.com +86 373 3029977 +86 373 3029977.
Miaomiao ZhangHenan Key Laboratory of Immunology and Targeted Therapy, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, School of Laboratory Medicine, Xinxiang Medical University Xinxiang 453003 PR China zhangyun0126@126.com +86 373 3029977 +86 373 3029977.
Jinjuan QiaoDepartment of Medical Laboratory, Weifang Medical University Weifang 261053 PR China.
Target (United States) · USXinxiang University · CNWeifang Medical University · CN
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
In this study, a novel colorimetric sensing platform was developed for the detection of
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A novel colorimetric sensing platform for the detection of · full record | OpenQuestion